International Assets Investment Management, LLC Provention Bio, Inc. Transaction History

International Assets Investment Management, LLC

  • $1.06 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 19, 2023
BUY
$6.7 - $24.21 $850 - $3,074
127 New
127 $3,000
Q2 2021

Jul 14, 2021
SELL
$6.71 - $11.04 $3,663 - $6,027
-546 Closed
0 $0
Q1 2021

Apr 19, 2021
BUY
$10.12 - $19.45 $3,501 - $6,729
346 Added 173.0%
546 $7,000
Q4 2020

Jan 22, 2021
BUY
$11.79 - $18.94 $2,358 - $3,788
200 New
200 $3.39 Million

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track International Assets Investment Management, LLC Portfolio

Follow International Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email